These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 162192)

  • 1. [Function studies of an atropine derivative--ipratropium bromide in an aerosol device--in patients with chronic obstructive bronchopneumopathies].
    Mairesse M; Ledent C
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):196-9. PubMed ID: 162192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ
    Ann Allergy; 1988 Nov; 61(5):341-3. PubMed ID: 2973269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of ipratropium bromide in aerosol administration on airway resistance and MEFV curves].
    Illiano A; Tranfa CM; Giacomelli P; Cantatore D; Donato Di Paola RM; Marsico SA
    Arch Monaldi; 1981; 36(3):105-17. PubMed ID: 6216870
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Atrovent administered by inhalation on pulmonary mechanics in patients with obstructive lung disease [proceedings].
    Koch G
    Scand J Respir Dis Suppl; 1979; 103():206-7. PubMed ID: 155300
    [No Abstract]   [Full Text] [Related]  

  • 5. High dose ipratropium bromide--is it safe?
    Leak A; O'Connor T
    Practitioner; 1988 Jan; 232(1441):9-10. PubMed ID: 2975378
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the method of inhalation of Berodual on bronchodilation in patients over 60 years of age with diffuse bronchial obstruction].
    Czernicka-Cierpisz E; Kościńska M; Radomyski A; Sliwiński P; Zieliński J
    Pneumonol Pol; 1988 Oct; 56(10):486-91. PubMed ID: 2978275
    [No Abstract]   [Full Text] [Related]  

  • 9. Ipratropium bromide and fenoterol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Br J Clin Pharmacol; 1982 Jul; 14(1):113-5. PubMed ID: 6213250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical comparison of Atrovent and a placebo in patients with chronic obstructive lung diseases].
    Lien JT
    Tidsskr Nor Laegeforen; 1980 Jul; 100(19-21):1193-5. PubMed ID: 6448492
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
    Brown IG; Chan CS; Kelly CA; Dent AG; Zimmerman PV
    Thorax; 1984 Apr; 39(4):272-6. PubMed ID: 6232724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the bronchodilating action of fenoterol and ipratropium bromide administered by aerosols in acute attacks of asthma].
    Della Toffola A; Ardizzi A; Giorgis GE; Galietti F; Massaglia GM; Onoscuri E
    Minerva Med; 1986 May; 77(22-23):1005-8. PubMed ID: 2941697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of ipratropium bromide in obstructive lung disease.
    Mann KV; Leon AL; Tietze KJ
    Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled clinical study of a long-term treatment of chronic obstructive lung disease using a combination of fenoterol and ipratropium bromide in aerosol form.
    Serra C; Giacopelli A
    Respiration; 1986; 50 Suppl 2():249-53. PubMed ID: 2951816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipratropium bromide aerosol in chronic bronchitis.
    Cummiskey J; Keelan P; Gray P; Cox GA
    Ir Med J; 1977 Oct; 70(15):445-7. PubMed ID: 144713
    [No Abstract]   [Full Text] [Related]  

  • 17. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma].
    Baños Hidalgo P; Ramos Martos A; Cabrera Moreno R; Luque Leal J; Palacios Giner A
    Rev Clin Esp; 1983 Nov; 171(4):265-8. PubMed ID: 6229844
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients.
    Charoenpan P; Kiatboonsri S; Uswanopakhun P; Vongvivat K; Sulaimanee P
    J Med Assoc Thai; 1990 Feb; 73(2):91-5. PubMed ID: 2141057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.